Lighthouse Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-42,245
Closed -$2.56M – 740
2026
Q1
$2.56M Buy
+42,245
New +$2.46M 0.09% 287
2024
Q4
– Sell
-10,004
Closed -$518K – 507
2024
Q3
$518K Sell
10,004
-34,722
-78% -$1.63M 0.02% 368
2024
Q2
$1.86M Sell
44,726
-64,343
-59% -$2.88M 0.07% 241
2024
Q1
$5.91M Buy
+109,069
New +$5.56M 0.27% 103

Other funds holding BMY

Lighthouse Investment Partners's BMY Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 42,245 shares — an estimated $2.56M sold.

Lighthouse Investment Partners first reported a position in BMY in Q1 2024 and held it in 4 quarters. The position peaked at $5.91M in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Lighthouse Investment Partners reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 42,245 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.56M.
  • Lighthouse Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 4 quarters.
  • Lighthouse Investment Partners's Bristol-Myers Squibb position peaked at $5.91M in Q1 2024.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.